Literature DB >> 19529988

A novel SACS gene mutation in a Tunisian family.

Yosr Bouhlal1, Ghada El Euch-Fayeche, Fayçal Hentati, Rim Amouri.   

Abstract

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a distinct form of hereditary early-onset spastic ataxia. In 2000, the causative gene, SACS, encoding the protein sacsin, was identified in Quebec patients. The open reading frame (ORF) of SACS was initially reported to contain 11,487 bp and to be encoded by a single gigantic exon. Recently, eight additional exons upstream of the original ORF were found (ENST00000382298). We report four Tunisian ARSACS patients homozygous for a novel mutation in SACS exon 9 gene, c.12846_12850delAGAG. This mutation is localized upstream from the DnaJ domain leading to the loss of this domain, suggesting that the disease is associated with loss of critical chaperone function of sacsin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19529988     DOI: 10.1007/s12031-009-9212-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  18 in total

1.  ARSACS, a spastic ataxia common in northeastern Québec, is caused by mutations in a new gene encoding an 11.5-kb ORF.

Authors:  J C Engert; P Bérubé; J Mercier; C Doré; P Lepage; B Ge; J P Bouchard; J Mathieu; S B Melançon; M Schalling; E S Lander; K Morgan; T J Hudson; A Richter
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

2.  ARSACS goes global.

Authors:  Christopher M Gomez
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

3.  A novel sacsin mutation in a Japanese woman showing clinical uniformity of autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  S Okawa; M Sugawara; S Watanabe; T Imota; I Toyoshima
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Yoshihisa Takiyama
Journal:  Neuropathology       Date:  2006-08       Impact factor: 1.906

5.  Novel compound heterozygous mutations in sacsin-related ataxia.

Authors:  Yoichi Yamamoto; Kotaro Hiraoka; Mutsuko Araki; Seiichi Nagano; Haruo Shimazaki; Yoshihisa Takiyama; Sabro Sakoda
Journal:  J Neurol Sci       Date:  2005-09-29       Impact factor: 3.181

6.  A phenotype without spasticity in sacsin-related ataxia.

Authors:  H Shimazaki; Y Takiyama; K Sakoe; Y Ando; I Nakano
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

7.  Autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  J P Bouchard; A Barbeau; R Bouchard; R W Bouchard
Journal:  Can J Neurol Sci       Date:  1978-02       Impact factor: 2.104

8.  Identification of a SACS gene missense mutation in ARSACS.

Authors:  T Ogawa; Y Takiyama; K Sakoe; K Mori; M Namekawa; H Shimazaki; I Nakano; M Nishizawa
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

9.  Novel SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay type.

Authors:  G S Grieco; A Malandrini; G Comanducci; V Leuzzi; M Valoppi; A Tessa; S Palmeri; L Benedetti; A Pierallini; S Gambelli; A Federico; F Pierelli; E Bertini; C Casali; F M Santorelli
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

10.  An unusual case of a spasticity-lacking phenotype with a novel SACS mutation.

Authors:  Haruo Shimazaki; Kumi Sakoe; Kenji Niijima; Imaharu Nakano; Yoshihisa Takiyama
Journal:  J Neurol Sci       Date:  2007-03-08       Impact factor: 3.181

View more
  6 in total

1.  Computational analysis of a novel SACS gene mutation with BioExtract server.

Authors:  Yosr Bouhlal; Douglas M Jennewein; Brent Anderson; Joe Reynoldson; Wiem Maamouri; Fayçal Hentati; Rim Amouri; Carol Lushbough
Journal:  J Mol Neurosci       Date:  2011-03-17       Impact factor: 3.444

Review 2.  A novel homozygous SACS mutation identified by whole exome sequencing-genotype phenotype correlations of all published cases.

Authors:  Georgia Xiromerisiou; Katerina Dadouli; Chrysoula Marogianni; Antonios Provatas; Panagiotis Ntellas; Dimitrios Rikos; Pantelis Stathis; Despina Georgouli; Gedeon Loules; Maria Zamanakou; Georgios M Hadjigeorgiou
Journal:  J Mol Neurosci       Date:  2019-11-07       Impact factor: 3.444

3.  Molecular diagnosis of known recessive ataxias by homozygosity mapping with SNP arrays.

Authors:  D H'mida-Ben Brahim; A M'zahem; M Assoum; Y Bouhlal; F Fattori; M Anheim; L Ali-Pacha; F Ferrat; M Chaouch; C Lagier-Tourenne; N Drouot; C Thibaut; T Benhassine; Y Sifi; D Stoppa-Lyonnet; K N'Guyen; J Poujet; A Hamri; F Hentati; R Amouri; F M Santorelli; M Tazir; M Koenig
Journal:  J Neurol       Date:  2010-08-27       Impact factor: 4.849

Review 4.  Discovery of Therapeutics Targeting Oxidative Stress in Autosomal Recessive Cerebellar Ataxia: A Systematic Review.

Authors:  Sze Yuen Lew; Michael Weng Lok Phang; Pit Shan Chong; Jaydeep Roy; Chi Him Poon; Wing Shan Yu; Lee Wei Lim; Kah Hui Wong
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-19

Review 5.  Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration.

Authors:  Jaya Bagaria; Eva Bagyinszky; Seong Soo A An
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 6.  Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.

Authors:  Marjolaine Tremblay; Laura Girard-Côté; Bernard Brais; Cynthia Gagnon
Journal:  Orphanet J Rare Dis       Date:  2022-10-01       Impact factor: 4.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.